A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
St. Jude Children's Research Hospital
National Institutes of Health Clinical Center (CC)
Seattle Children's Hospital
Milton S. Hershey Medical Center
The University of Texas Health Science Center, Houston